Drug Profile
Research programme: anticancer therapeutics - Bioceltran
Alternative Names: Photodynamic therapy and protein transduction technology derived anticancer therapeutics - Bioceltran; PTD/PDT anticancer therapeutics - BioceltranLatest Information Update: 30 Sep 2022
Price :
$50
*
At a glance
- Originator Bioceltran
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Sep 2022 Bioceltran terminated and returned Photodynamic therapy technology from Quest Pharma Tech
- 28 Nov 2018 No recent reports of development identified for research development in Cancer in South Korea (Topical)
- 02 Oct 2014 Bioceltran in-licenses Photodynamic therapy technology from Quest Pharma Tech